19 Nov, 2020, 09:00 ET
DUBLIN, Nov. 19, 2020 /PRNewswire/ -- The "Sleeping Aids Market Research Report: By Offering, Sleep Disorder - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
The global sleeping aids market generated a revenue of $78.7 billion in 2019 and is predicted to progress at a CAGR of 7.1% from 2020 to 2030 to attain a value of $162.5 billion by 2030.
The major factors driving the progress of the market are the increasing number of healthcare facilities, growing usage of portable sleep apnea devices, and the rising adoption of sensors and wearable monitors.
Besides the aforementioned factors, the increasing prevalence of obstructive sleep apnea (OSA) and insomnia and the soaring geriatric population around the world are also propelling the expansion of the sleeping aids market. As per the findings of the American Sleep Apnea Association, over 50 million Americans are diagnosed with 80 different sleep disorders every year. Moreover, the organization found that 20 - 30 million people in the U.S. suffer from various intermittent sleep problems every year.
According to the organization, insomnia is the most prevalent sleep disorder, with nearly 30% of the adults living in the U.S. reporting short-term issues and around 10% reporting chronic insomnia. As the medical treatments prescribed for OSA and insomnia involve sleeping aids, the rising incidence of these disorders is fueling the growth of the market. Besides this, the various lifestyle changes in people such as the high consumption of caffeine, tobacco, and alcohol is also propelling the market advancement.
Furthermore, the increasing working hours, high workload and work pressure, and hectic work environment massively push up the stress levels and affect the quality of sleep. This subsequently boosts the sales of over-the-counter (OTC) sleeping pills, which help improve the quality of sleep, throughout the globe. When offering is taken into consideration, the sleeping aids market is classified into mattresses and pillows, sleep laboratory services, sleep apnea devices, and medication.
Key Topics Covered:
Chapter 1. Research Background
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Offering
184.108.40.206 Mattresses and pillows
220.127.116.11 Sleep laboratory services
18.104.22.168.1 Prescription drugs
22.214.171.124.2 OTC drugs
126.96.36.199.3 Herbal remedies
188.8.131.52 Sleep apnea devices
184.108.40.206.1 PAP devices
220.127.116.11.2 Facial interface
18.104.22.168.3 Oral appliances
4.1.2 By Sleep Disorder
22.214.171.124 Sleep apnea
126.96.36.199 Sleep walking
4.2 Market Dynamics
188.8.131.52 Shifting consumer preference toward herbal OTC drugs
184.108.40.206 Increasing demand for home sleep tests
220.127.116.11 Increased usage of CPAP therapy devices
18.104.22.168 Growing prevalence of insomnia and OSA
22.214.171.124 Rising use of portable sleep apnea devices
126.96.36.199 Increasing government support for startup companies
188.8.131.52 Growing network of healthcare facilities
184.108.40.206 Growing adoption of wearable monitors and sensors
220.127.116.11 Surge in demand for sleeping pills, attributed to stressful modern lifestyle
18.104.22.168 Increasing geriatric population
22.214.171.124 Impact analysis of drivers on market forecast
126.96.36.199 Long waiting time for sleep care services
188.8.131.52 Shortage of skilled medical professionals
184.108.40.206 Patent expiration of sleep disorder medications
220.127.116.11 Side-effects associated with sleep medications
18.104.22.168 Impact analysis of restraints on market forecast
22.214.171.124 Rising disposable income
126.96.36.199 Increasing patient pool in emerging economies
188.8.131.52 Initiatives by various organizations for increasing awareness
4.3 Porter's Five Forces Analysis
4.4 Impact of COVID-19
Chapter 5. Global Market Size and Forecast
5.1 By Offering
5.1.1 Sleeping Aid Medication Market, by Type
5.1.2 Sleep Apnea Devices Market, by Type
5.2 By Sleep Disorder
5.3 By Region
Chapter 6. North America Market Size and Forecast
Chapter 7. Europe Market Size and Forecast
Chapter 8. APAC Market Size and Forecast
Chapter 9. LATAM Market Size and Forecast
Chapter 10. MEA Market Size and Forecast
Chapter 11. Competitive Landscape
11.1 Product Benchmarking of Key Players
11.2 Strategic Developments of Key Players
11.2.1 Product Launches and Approvals
11.2.2 Mergers and Acquisitions
11.2.3 Partnerships, Collaborations and Agreements
Chapter 12. Company Profiles
12.1 Business Overview
12.2 Product and Service Offerings
12.3 Key Financial Summary
- Merck & Co. Inc.
- Koninklijke Philips N.V.
- Pfizer Inc.
- SleepMed Inc.
- Cadwell Industries Inc.
- Natus Medical Incorporated
- Drive DeVilbiss Healthcare
- Takeda Pharmaceutical Company Limited
- Compumedics Limited
- Tempur Sealy International Inc.
- GlaxoSmithKline plc
- Serta Simmons Bedding LLC
- ResMed Inc.
- Fisher & Paykel Healthcare Limited
- Lowenstein Medical GmbH & Co. KG
- BMC Medical Co. Ltd.
- SomnoMed Limited
- Braebon Medical Corporation
For more information about this report visit https://www.researchandmarkets.com/r/ig9mch
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article